Referencias

1. Nahas GG. The medical use of cannabis. En. Nahas GG, eds. Marihuana in Science and Medicine. New York: Raven Press; 1984.
2. Hall W, Solowji N, Lemon J. The health and psychological consequences of cannabis use. Monograph Series No. 25. National Task Force on Cannabis; 1994.
3. Hollister LE. Marijuana and immunity. J Psychoactive Drugs 1988;20(1):3-8.
4. Agurell S, Dewey WL, Willett RE, eds. The Cannabinoids: chemical, pharmacologic, and therapeutic aspects. New York: Academic Press; 1984.
5. Maykut MO. Health consequences of acute and chronic marihuana use. Prog Neuropsychopharmacol Biol Psychiatry 1985;9:209-38.
6. Institute of Medicine. Division of Health Sciences Policy. Marijuana and Health: Report of a Study by a Committee of the Institute of Medicine, Division of Health Sciences Policy. Washington, DC: National Academy Press; 1982.
7. Association for Cannabis as Medicine, Boletín On-line 2 de Mayo de 1999.
8. Segal M. Cannabionids and analgesia. En: Mechoulam R., ed. Cannabinoids as therapeutic agents. Boca Ratón, Florida: CRC Press; 1986.
9. Grinspoon L, Bakalar JB. Marihuana, the Forbidden Medicine. New Haven: Yale University Press; 1993.
10. Consroe P, Laguna J, Allender J, Snider S, Stern L, Sandyk R, Kennedy K, Schram K. Controled trial of cannabidiol in Huntington's disease. Pharm Bioch Behav 1991;40:701-8.
11. Giuffrida A, Parsons LH, Kerr TM, Rodríguez de Fonseca F, Navarro M, Piomelli D. Dopamine activation of endogenous cannabinoid signalling in dorsal striatum. Nature Neurosc 1999;2(4):358-63.
12. Müller-Vahl KR, Kolbe H, Schneider U, Emrich HM. Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourrette syndrome. Acta Psychiatr Scand 1998;98;502-6.
13. Ungerleider JT, Andrysiak T, Fairbanks T, Goodnight J, Sarna G , Jamison K. Cannabis and cancer chemotherapy: A comparison of oral delta-9-THC and prochlorperazine. Cancer 1982;50:636-45.
14. Dobin RE, Kleiman MAR. Marijuana as antiemetic medicine: A survey of oncologists experience and attitudes. J Clin Oncology 1991;9:1314-9.
15. American Academy of Ophtalmology. The use of marijuana in the treatment of glaucoma, June 21. Reproducido en: R. Randall R., ed. Cancer Treatment and Maijuana Therapy. Washington, DC: Galen Press; 1990.
16. Plasse TF, Gorter RW, Krasnow SH, Lane M, Shapartd KV, Waldeigh R. Recent clinical experience with Dronabiol. Pharmac Bioch Behav 1981;40:695-700.
17. Graham JDP. The bronchodilatador action of cannabinoids. En: Mechoulam R., ed. Cannabinoids as Therapeutic Agents. Boca Ratón, Florida: CRC Press; 1986.
18. Solowji N. Cannabis and cognitive functioning. International Monographs in the Addictions. Cambridge University Press; 1999.